159 related articles for article (PubMed ID: 27203389)
1. Inhibition of chronic lymphocytic leukemia progression by full-length chromogranin A and its N-terminal fragment in mouse models.
Bianco M; Gasparri A; Generoso L; Assi E; Colombo B; Scarfò L; Bertilaccio MT; Scielzo C; Ranghetti P; Dondossola E; Ponzoni M; Caligaris-Cappio F; Ghia P; Corti A
Oncotarget; 2016 Jul; 7(27):41725-41736. PubMed ID: 27203389
[TBL] [Abstract][Full Text] [Related]
2. Regulation of tumor growth by circulating full-length chromogranin A.
Curnis F; Dallatomasina A; Bianco M; Gasparri A; Sacchi A; Colombo B; Fiocchi M; Perani L; Venturini M; Tacchetti C; Sen S; Borges R; Dondossola E; Esposito A; Mahata SK; Corti A
Oncotarget; 2016 Nov; 7(45):72716-72732. PubMed ID: 27683038
[TBL] [Abstract][Full Text] [Related]
3. Plasma levels of vasostatin-1, a chromogranin A fragment, are associated with carotid artery maximum stenosis: A pilot study.
Bachetti T; Ferrari Bardile A; Aloi TL; Colombo B; Assi E; Savino G; Vercelli A; Colombo R; Corti A
Int J Cardiol; 2017 Jun; 236():438-443. PubMed ID: 28190616
[TBL] [Abstract][Full Text] [Related]
4. Vasostatin-1: A novel circulating biomarker for ileal and pancreatic neuroendocrine neoplasms.
Corsello A; Di Filippo L; Massironi S; Sileo F; Dolcetta Capuzzo A; Gemma M; Carlucci C; Cusini C; Colombo B; Dallatomasina A; Franchi GM; Corti A; Manzoni MF
PLoS One; 2018; 13(5):e0196858. PubMed ID: 29723285
[TBL] [Abstract][Full Text] [Related]
5. Chronic lymphocytic leukemia cells in a lymph node microenvironment depict molecular signature associated with an aggressive disease.
Mittal AK; Chaturvedi NK; Rai KJ; Gilling-Cutucache CE; Nordgren TM; Moragues M; Lu R; Opavsky R; Bociek GR; Weisenburger DD; Iqbal J; Joshi SS
Mol Med; 2014 Jul; 20(1):290-301. PubMed ID: 24800836
[TBL] [Abstract][Full Text] [Related]
6. Chromogranin-A production and fragmentation in patients with Takayasu arteritis.
Tombetti E; Colombo B; Di Chio MC; Sartorelli S; Papa M; Salerno A; Bozzolo EP; Tombolini E; Benedetti G; Godi C; Lanzani C; Rovere-Querini P; Del Maschio A; Ambrosi A; De Cobelli F; Sabbadini MG; Baldissera E; Corti A; Manfredi AA
Arthritis Res Ther; 2016 Aug; 18():187. PubMed ID: 27531191
[TBL] [Abstract][Full Text] [Related]
7. HS1 has a central role in the trafficking and homing of leukemic B cells.
Scielzo C; Bertilaccio MT; Simonetti G; Dagklis A; ten Hacken E; Fazi C; Muzio M; Caiolfa V; Kitamura D; Restuccia U; Bachi A; Rocchi M; Ponzoni M; Ghia P; Caligaris-Cappio F
Blood; 2010 Nov; 116(18):3537-46. PubMed ID: 20530793
[TBL] [Abstract][Full Text] [Related]
8. Absence of caveolin-1 leads to delayed development of chronic lymphocytic leukemia in Eμ-TCL1 mouse model.
Shukla A; Cutucache CE; Sutton GL; Pitner MA; Rai K; Rai S; Opavsky R; Swanson PC; Joshi SS
Exp Hematol; 2016 Jan; 44(1):30-7.e1. PubMed ID: 26435347
[TBL] [Abstract][Full Text] [Related]
9. Chromogranin A and its fragments in cardiovascular, immunometabolic, and cancer regulation.
Mahata SK; Corti A
Ann N Y Acad Sci; 2019 Nov; 1455(1):34-58. PubMed ID: 31588572
[TBL] [Abstract][Full Text] [Related]
10. Quantification of Chromogranin A and Its Fragments in Biological Fluids.
Curnis F; Colombo B; Corti A
Methods Mol Biol; 2023; 2565():343-359. PubMed ID: 36205905
[TBL] [Abstract][Full Text] [Related]
11. Chromogranin A (CGA)-derived polypeptide (CGA
Luo L; Liu S; Zhang D; Wei F; Gu N; Zeng Y; Chen X; Xu S; Liu S; Xiang T
Peptides; 2020 Sep; 131():170297. PubMed ID: 32380199
[TBL] [Abstract][Full Text] [Related]
12. Chromogranin A Is Preferentially Cleaved into Proangiogenic Peptides in the Bone Marrow of Multiple Myeloma Patients.
Bianco M; Gasparri AM; Colombo B; Curnis F; Girlanda S; Ponzoni M; Bertilaccio MT; Calcinotto A; Sacchi A; Ferrero E; Ferrarini M; Chesi M; Bergsagel PL; Bellone M; Tonon G; Ciceri F; Marcatti M; Caligaris-Cappio F; Corti A
Cancer Res; 2016 Apr; 76(7):1781-91. PubMed ID: 26869462
[TBL] [Abstract][Full Text] [Related]
13. Chromogranin A and the endothelial barrier function.
Corti A; Ferrero E
Curr Med Chem; 2012; 19(24):4051-8. PubMed ID: 22834794
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of progelatinase B/proMMP-9 affects migration regulatory pathways and impairs chronic lymphocytic leukemia cell homing to bone marrow and spleen.
Bailón E; Ugarte-Berzal E; Amigo-Jiménez I; Van den Steen P; Opdenakker G; García-Marco JA; García-Pardo A
J Leukoc Biol; 2014 Aug; 96(2):185-99. PubMed ID: 25080557
[TBL] [Abstract][Full Text] [Related]
15. The vasostatin-I fragment of chromogranin A inhibits VEGF-induced endothelial cell proliferation and migration.
Belloni D; Scabini S; Foglieni C; Veschini L; Giazzon A; Colombo B; Fulgenzi A; Helle KB; Ferrero ME; Corti A; Ferrero E
FASEB J; 2007 Oct; 21(12):3052-62. PubMed ID: 17566084
[TBL] [Abstract][Full Text] [Related]
16. Relaxation induced by N-terminal fragments of chromogranin A in mouse gastric preparations.
Amato A; Serio R; Mulè F
Regul Pept; 2007 Mar; 139(1-3):90-5. PubMed ID: 17126925
[TBL] [Abstract][Full Text] [Related]
17. Circulating B-cell chronic lymphocytic leukemia cells display impaired migration to lymph nodes and bone marrow.
Hartmann TN; Grabovsky V; Wang W; Desch P; Rubenzer G; Wollner S; Binsky I; Vallon-Eberhard A; Sapoznikov A; Burger M; Shachar I; Haran M; Honczarenko M; Greil R; Alon R
Cancer Res; 2009 Apr; 69(7):3121-30. PubMed ID: 19293181
[TBL] [Abstract][Full Text] [Related]
18. The chromogranin A peptide vasostatin-I inhibits gap formation and signal transduction mediated by inflammatory agents in cultured bovine pulmonary and coronary arterial endothelial cells.
Blois A; Srebro B; Mandalà M; Corti A; Helle KB; Serck-Hanssen G
Regul Pept; 2006 Jul; 135(1-2):78-84. PubMed ID: 16725215
[TBL] [Abstract][Full Text] [Related]
19. Triterpenoids display single agent anti-tumor activity in a transgenic mouse model of chronic lymphocytic leukemia and small B cell lymphoma.
Kress CL; Konopleva M; Martínez-García V; Krajewska M; Lefebvre S; Hyer ML; McQueen T; Andreeff M; Reed JC; Zapata JM
PLoS One; 2007 Jun; 2(6):e559. PubMed ID: 17593960
[TBL] [Abstract][Full Text] [Related]
20. Circulating Chromogranin A Is Cleaved Into Vasoregulatory Fragments in Patients With Pancreatic Ductal Adenocarcinoma.
Reni M; Andreasi V; Gasparri AM; Dugnani E; Colombo B; Macchini M; Bianco M; Dallatomasina A; Citro A; Assi E; Protti MP; Esposito A; Falconi M; Curnis F; Piemonti L; Corti A
Front Oncol; 2020; 10():613582. PubMed ID: 33425767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
